ARCHIVES

Groups Advise NCI On “Investment Opportunities”

This article is from The Cancer Letter archive.

Vol. 22 No. 26 | June 28, 1996

Download PDF Visit The Full Archive

Related Articles

Survey Finds. Bush Signs Stopgap Funding Measure;

October 5, 2007

Cooperation Is ACS Theme For ‘90s; Dodd

February 1, 1991

Aggressive, Tailored Therapy Improves Survival, Study Finds

October 31, 2008

NCI RFP Available.

February 11, 2000

Final Issue Of ‘77

December 16, 1977

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004